IL-7 is superior to IL-2 for ex vivo expansion of tumourspecific CD4 + T cells

European Journal of Immunology

Volumn 40, Issue 2, 2010, Pages 470-479

  Caserta, Stefano ^a,b,c   Alessi, Patrizia ^a,d   Basso, Veronica ^a   Mondino, Anna ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Adoptive T cell therapy; Cytokines; T helper cells; Tumour immunology

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 7; TUMOR ANTIGEN;

ARTICLE; CANCER PREVENTION; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL HOMING; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CELL VIABILITY; EX VIVO STUDY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-6; INTERLEUKIN-7; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL;

EID: 75149127319     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939801     Document Type: Article

References (57)

1. Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A. and Dudley,M. E., Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 2008. 8: 299-308.
2. Gattinoni, L., Klebanoff, C. A., Palmer, D. C., Wrzesinski, C., Kerstann, K., Yu, Z., Finkelstein, S. E. et al., Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8(+) T cells. J. Clin. Invest. 2005. 115: 1616-1626.
3. Klebanoff, C. A., Gattinoni, L., Torabi-Parizi, P., Kerstann, K., Cardones, A. R., Finkelstein, S. E., Palmer, D. C. et al., Central memory self/tumor-reactive CD8+T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. USA 2005. 102: 9571-9576.
4. Topalian, S. L., MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy. Curr. Opin. Immunol. 1994. 6: 741-745.
5. Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D. and Levitsky, H., The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med. 1998. 188: 2357-2368.
6. Pardoll, D. M. and Topalian, S. L., The role of CD4+T cell responses in antitumor immunity. Curr. Opin. Immunol. 1998. 10: 588-594.
7. Marzo, A. L., Kinnear, B. F., Lake, R. A., Frelinger, J. J., Collins, E. J., Robinson, B.W. and Scott, B., Tumor-specific CD4(+) T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity. J. Immunol. 2000. 165: 6047-6055.
8. Klein, L., Trautman, L., Psarras, S., Schnell, S., Siermann, A., Liblau, R., von Boehmer, H. and Khazaie, K., Visualizing the course of antigenspecific CD8 and CD4 T cell responses to a growing tumor. Eur. J. Immunol. 2003. 33: 806-814.
9. Qin, Z. and Blankenstein, T., CD4+T cell - mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 2000. 12: 677-686.
10. Benigni, F., Zimmermann, V. S., Hugues, S., Caserta, S., Basso, V., Rivino, L., Ingulli, E., Malherbe, L. et al., Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk. J. Immunol. 2005. 175: 739-748.
11. Staveley-O'Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D. and Levitsky, H., Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc. Natl. Acad. Sci. USA 1998. 95: 1178-1183.
12. Shrikant, P., Khoruts, A. and Mescher, M. F., CTLA-4 blockade reverses CD8+T cell tolerance to tumor by a CD4+T cell- and IL-2-dependent mechanism. Immunity 1999. 11: 483-493.
13. Hernandez, J., Aung, S., Redmond, W. L. and Sherman, L. A., Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 2001. 194: 707-717.
14. Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A. and Schreiber, H., Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J. Exp. Med. 1997. 186: 229-238.
15. Zimmermann, V. S., Casati, A., Schiering, C., Caserta, S., Michelini, R. H., Basso, V. and Mondino, A., Tumors hamper the immunogenic competence of CD4+T cell-directed dendritic cell vaccination. J. Immunol. 2007. 179: 2899-2909.
16. Fuller, M. J. and Zajac, A. J., Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 2003. 170: 477-486.
17. Harari, A., Petitpierre, S., Vallelian, F. and Pantaleo, G., Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004. 103: 966-972.
18. Pantaleo, G. and Harari, A., Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 2006. 6: 417-423.
19. Jelley-Gibbs, D. M., Dibble, J. P., Filipson, S., Haynes, L., Kemp, R. A. and Swain, S. L., Repeated stimulation of CD4 effector T cells can limit their protective function. J. Exp. Med. 2005. 201: 1101-1112.
20. Dooms, H. and Abbas, A. K., Control of CD4+T-cell memory by cytokines and costimulators. Immunol. Rev. 2006. 211: 23-38.
21. Stockinger, B., Bourgeois, C. and Kassiotis, G., CD4+memory T cells: functional differentiation and homeostasis. Immunol. Rev. 2006. 211: 39-48.
22. Swain, S. L., Agrewala, J. N., Brown, D. M., Jelley-Gibbs, D. M., Golech, S., Huston, G., Jones, S. C., CD4+T-cell memory: generation and multifaceted roles for CD4+T cells in protective immunity to influenza. Immunol. Rev. 2006. 211: 8-22.
23. Caserta, S. and Zamoyska, R., Memories are made of this: synergy of T cell receptor and cytokine signals in CD4(+) central memory cell survival. Trends Immunol. 2007. 28: 245-248.
24. Unutmaz, D., Pileri, P. and Abrignani, S., Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 1994. 180: 1159-1164.
25. Kanegane, H. and Tosato, G., Activation of naive and memory T cells by interleukin-15. Blood 1996. 88: 230-235.
26. Geginat, J., Sallusto, F. and Lanzavecchia, A., Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J. Exp. Med. 2001. 194: 1711-1719.
27. Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J. and Surh, C. D., Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+cells but are not required for memory phenotype CD4+cells. J. Exp. Med. 2002. 195: 1523-1532.
28. Jaleco, S., Swainson, L., Dardalhon, V., Burjanadze, M., Kinet, S. and Taylor, N., Homeostasis of naive and memory CD4+T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fasmediated apoptosis. J. Immunol. 2003. 171: 61-68.
29. Klebanoff, C. A., Finkelstein, S. E., Surman, D. R., Lichtman, M. K., Gattinoni, L., Theoret, M. R., Grewal, N. et al., IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+T cells. Proc. Natl. Acad. Sci. USA 2004. 101: 1969-1974.
30. Seddon, B. and Zamoyska, R., TCR and IL-7 receptor signals can operate independently or synergize to promote lymphopenia-induced expansion of naive T cells. J. Immunol. 2002. 169: 3752-3759.
31. Seddon, B., Tomlinson, P. and Zamoyska, R., Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 2003. 4: 680-686.
32. Cohen, P. A., Kim, H., Fowler, D. H., Gress, R. E., Jakobsen, M. K., Alexander, R. B., Mule, J. J. et al., Use of interleukin-7, interleukin-2, and interferon-gamma to propagate CD4+T cells in culture with maintained antigen specificity. J. Immunother. 1993. 14: 242-252.
33. Jennes, W., Kestens, L., Nixon, D. F. and Shacklett, B. L., Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15 - the Amplispot assay. J. Immunol. Methods 2002. 270: 99-108.
34. Jackson, H. M., Dimopoulos, N., Chen, Q., Luke, T., Yee Tai, T., Maraskovsky, E., Old, L. J. et al., A robust human T-cell culture method suitable for monitoring CD8+and CD4+T-cell responses from cancer clinical trial samples. J. Immunol. Methods 2004. 291: 51-62.
35. Chen, H. W., Liao, C. H., Ying, C., Chang, C. J. and Lin, C. M., Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Clin. Immunol. 2006. 119: 21-31.
36. Liu, S., Riley, J., Rosenberg, S. and Parkhurst, M., Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy. J. Immunother. 2006. 29: 284-293.
37. Li, J., Huston, G. and Swain, S. L., IL-7 promotes the transition of CD4 effectors to persistent memory cells. J. Exp. Med. 2003. 198: 1807-1815.
38. Kondrack, R. M., Harbertson, J., Tan, J. T., McBreen, M. E., Surh, C. D. and Bradley, L. M., Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 2003. 198: 1797-1806.
39. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D. and Ahmed, R., Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 2003. 4: 1191-1198.
40. Geginat, J., Campagnaro, S., Sallusto, F. and Lanzavecchia, A., TCRindependent proliferation and differentiation of human CD4+T cell subsets induced by cytokines. Adv. Exp. Med. Biol. 2002. 512: 107-112.
41. Nanjappa, S. G.,Walent, J. H., Morre, M. and Suresh, M., Effects of IL-7 on memory CD8 T cell homeostasis are influenced by the timing of therapy in mice. J. Clin. Invest. 2008. 118: 1027-1039.
42. Pellegrini, M., Calzascia, T., Elford, A. R., Shahinian, A., Lin, A. E., Dissanayake, D., Dhanji, S. et al., Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat. Med. 2009. 15: 528-536.
43. Colombetti, S., Levy, F. and Chapatte, L., IL-7 adjuvant treatment enhances long-term tumor antigen-specific CD8+T-cell responses after immunization with recombinant lentivector. Blood 2009. 113: 6629-6637.
44. Malherbe, L., Filippi, C., Julia, V., Foucras, G., Moro, M., Appel, H., Wucherpfennig, K. et al., Selective activation and expansion of high-affinity CD4+T cells in resistant mice upon infection with Leishmania major. Immunity 2000. 13: 771-782.
45. Swainson, L., Verhoeyen, E., Cosset, F. L. and Taylor, N., IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes. J. Immunol. 2006. 176: 6702-6708.
46. Gattinoni, L., Finkelstein, S. E., Klebanoff, C. A., Antony, P. A., Palmer, D. C., Spiess, P. J., Hwang, L. N. et al., Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+T cells. J. Exp. Med. 2005. 202: 907-912.
47. Rosato, A., Santa, S. D., Zoso, A., Giacomelli, S., Milan, G., Macino, B., Tosello, V. et al., The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. Cancer Res. 2003. 63: 2158-2163.
48. Bradley, L. M., Haynes, L. and Swain, S. L., IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 2005. 26: 172-176.
49. Hammerbeck, C. D. and Mescher, M. F., Antigen controls IL-7R alpha expression levels on CD8 T cells during full activation or tolerance induction. J. Immunol. 2008. 180: 2107-2116.
50. Gett, A. V., Sallusto, F., Lanzavecchia, A. and Geginat, J., T cell fitness determined by signal strength. Nat. Immunol. 2003. 4: 355-360.
51. Le, H. K., Graham, L., Miller, C. H., Kmieciak, M., Manjili, M. H. and Bear, H. D., Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1+ionomycin in IL-7+IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2. Cancer Immunol. Immunother. 2009. 58: 1565-1576.
52. Kittipatarin, C. and Khaled, A. R., Ex vivo expansion of memory CD8 T cells from lymph nodes or spleen through in vitro culture with interleukin-7. J. Immunol. Methods 2009. 344: 45-57.
53. Gattinoni, L., Powell, D. J., Jr., Rosenberg, S. A. and Restifo, N. P., Adoptive immunotherapy for cancer: building on success. Nat. Rev. Immunol. 2006. 6: 383-393.
54. Kaneko, S., Mastaglio, S., Bondanza, A., Ponzoni, M., Sanvito, F., Aldrighetti, L., Radrizzani, M. et al., IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. Blood 2009. 113: 1000-1015.
55. Lollini, P. L., de Giovanni, C., Eusebi, V., Nicoletti, G., Prodi, G. and Nanni, P., High-metastatic clones selected in vitro from a recent spontaneous BALB/c mammary adenocarcinoma cell line. Clin. Exp. Metastasis 1984. 2: 251-259.
56. Korsmeyer, S. J., Shutter, J. R., Veis, D. J., Merry, D. E. and Oltvai, Z. N., Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer. Biol. 1993. 4: 327-332.
57. Caserta, S., Alessi, P., Guarnerio, J., Basso, V. and Mondino, A., Synthetic CD4+T cell-targeted antigen-presenting cells elicit protective antitumor responses. Cancer Res. 2008. 68: 3010-3018.